Justin Eyquem I TBC

  • Speaker: Justin Eyquem, Principal Investigator, Parker Fellow. Microbiology & Immunotherapy, University of California, San Francisco
  • Talk title: TBC
  • Host: Joaquin Arribas
  • Date & time: Friday 27th October, at 17:00 CET
  • Online session. Registration


I received my PhD from the University of Paris-Diderot in collaboration with the biotech company Cellectis. During my PhD, I participated to the development of gene editing tools such as Meganuclease or TALEN in primary human cells and notably identified genomic location for safe integration of therapeutic genes. In 2014, I joined Michel Sadelain’s lab at the MSKCC and used CRISPR/Cas9 to engineer CAR T cells. I showed how targeting CAR transgene into specific loci enhance T cell efficacy, advance CAR immuno-biology and facilitate T cell manufacturing. Early 2019, I received the Parker Fellow Award and opened my lab in the department of Microbiology and Immunology at UCSF where I am developing a gene editing platform to enhance CAR T and NK cell functions in hematological and solid tumors.


Oct 27 2022


5:00 pm - 6:00 pm